Pulse Biosciences, Inc.

    Jurisdiction
    United States
    LEI
    529900NJUBI06118FM73
    ISIN
    US74587B1017 (PLSE)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    InsiderPie Expert Score
    trending_flat 47 / 100
    Worse than peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €713.86K
    Gross margin
    -64.2%
    EBIT
    -€61.98M
    EBIT margin
    -8,682.1%
    Net income
    -€58.37M
    Net margin
    -8,176.4%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: August 12, 2025

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 68K $1.09M +45K Buy

    Add to watchlist

    Notifications